Send feedback

CEL p.Val670fs

c.2008_2039del · VCV3779042

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
ultra-rare (popmax 0.0359%, nfe)
Conditions
1
maturity-onset diabetes of the young type 8

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDescapespremature termination codon in the last exon (11 of 11) — the truncated protein is likely expressed. PVS1 input, not an applied code
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP -2
Overall
CADD22.5PHRED · no single calibrated threshold — expert panels disagree
Region caveats
Repeat contexttandemchr9:133080625 segmental duplication, simple repeat · ambiguous alignment · reads may not map uniquely · confidence, not pathogenicity

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0359% European (non-Finnish) · 151/420,714 alleles
Filtering AF 0.0312% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0294%
Overall 0.0343% 191/557,030 alleles · ultra-rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0932% 1,074
Remaining individualsnot grpmax-eligible 0.054% 1,851
Ashkenazi Jewishnot grpmax-eligible 0.0457% 2,188
European (non-Finnish)grpmax 0.0359% 2,786
Admixed American 0.0296% 3,375
African / African-American 0.0078% 12,821
South Asian 0.00585% 17,083

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CEL
Protein
p.Val670fs
Coding
c.2008_2039del
MANE Select
NM_001807
Type
Deletion
Location
chr9:133071501 (GRCh38)
Gene constraint
LOEUF 0.972 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.10 · 7 PDB
Residue 670
the 'disordered' region; the '17 x 11 aa tandem repeats, glycodomain, o-linked (mucin type)' region
Full CEL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

maturity-onset diabetes of the young type 8 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For MODY (Orphanet):

Inheritance
Autosomal dominant, Not applicable
Onset
Adolescent, Adult, Childhood
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cel-p-val670fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown